Jonathan Allan - Mar 15, 2023 Form 3 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
General Counsel & Corp Sec
Signature
/s/ Stephen Tulipano, Attorney-in-Fact
Stock symbol
STOK
Transactions as of
Mar 15, 2023
Transactions value $
$0
Form type
3
Date filed
3/17/2023, 03:40 PM
Next filing
Jun 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding STOK Common Stock 1.95K Mar 15, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding STOK Employee Stock Option (Right to Buy) Mar 15, 2023 Common Stock 65K $59.84 Direct F1
holding STOK Employee Stock Option (Right to Buy) Mar 15, 2023 Common Stock 121K $20.34 Direct F2
holding STOK Employee Stock Option (Right to Buy) Mar 15, 2023 Common Stock 34.4K $7.07 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested as to 1/4th of the total shares on February 16, 2022, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
F2 The option vests as to 1/48th of the total shares on April 15, 2022 and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
F3 The option vests as to 1/48th of the total shares on January 7, 2023 and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.

Remarks:

Exhibit 24.1 - Power of Attorney